Neuroprotection via nAChRs: the role of nAChRs in neurodegenerative disorders such as Alzheimer's and Parkinson's disease.
about
Multiple roles for nicotine in Parkinson's diseaseNicotinic modulation of glutamate receptor function at nerve terminal level: a fine-tuning of synaptic signalsExposure of neonatal rats to parathion elicits sex-selective impairment of acetylcholine systems in brain regions during adolescence and adulthoodGender differences in the effect of tobacco use on brain phosphocreatine levels in methamphetamine-dependent subjectsMechanisms of inhibition and potentiation of α4β2 nicotinic acetylcholine receptors by members of the Ly6 protein familySignificant modulation of mitochondrial electron transport system by nicotine in various rat brain regionsSLEEPLESS is a bifunctional regulator of excitability and cholinergic synaptic transmissionNicotine mediates expression of genes related to antioxidant capacity and oxidative stress response in HIV-1 transgenic rat brain.Nicotinic ligands as multifunctional agents for the treatment of neuropsychiatric disordersEvaluation of nicotine and cotinine analogs as potential neuroprotective agents for Alzheimer's disease.Nicotinic receptors in the dorsal and ventral hippocampus differentially modulate contextual fear conditioning.Modulation of hippocampus-dependent learning and synaptic plasticity by nicotine.Effects of nicotine on depressive-like behavior and hippocampal volume of female WKY rats.Role for the nicotinic cholinergic system in movement disorders; therapeutic implications.α7 Nicotinic receptor activation reduces β-amyloid-induced apoptosis by inhibiting caspase-independent death through phosphatidylinositol 3-kinase signaling.The neuronal nicotinic alpha4beta2 receptor has a high maximal probability of being open.Nicotine: specific role in angiogenesis, proliferation and apoptosis.Nicotine as a potential neuroprotective agent for Parkinson's disease.α6ß2* and α4ß2* nicotinic receptors both regulate dopamine signaling with increased nigrostriatal damage: relevance to Parkinson's diseaseLearning and nicotine interact to increase CREB phosphorylation at the jnk1 promoter in the hippocampusRyanodine receptor-2 upregulation and nicotine-mediated plasticity.Nicotine aggravates the brain postischemic inflammatory response.Focus on α4β2* and α6β2* nAChRs for Parkinson's Disease Therapeutics.Chronic nicotine treatment increases nAChRs and microglial expression in monkey substantia nigra after nigrostriatal damageComparison of newly diagnosed ocular hypertension and open-angle glaucoma: ocular variables, risk factors, and disease severity.The effects of acute, chronic, and withdrawal from chronic nicotine on novel and spatial object recognition in male C57BL/6J mice.Lynx1 supports neuronal health in the mouse dorsal striatum during aging: an ultrastructural investigation.α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease.Altered human brain anatomy in chronic smokers: a review of magnetic resonance imaging studies.Untangling interactions of a zinc(II) complex containing a coumarin-porphyrin unit with alkaloids in water solutions: a photophysical study.GAMPMS: Genetic algorithm managed peptide mutant screening.Role of α6 nicotinic receptors in CNS dopaminergic function: relevance to addiction and neurological disorders.Nicotine reduces antipsychotic-induced orofacial dyskinesia in rats.Positive and negative effects of alcohol and nicotine and their interactions: a mechanistic review.Synthesis of selective agonists for the α7 nicotinic acetylcholine receptor with in situ click-chemistry on acetylcholine-binding protein templates.α4β2 Nicotinic receptors play a role in the nAChR-mediated decline in L-dopa-induced dyskinesias in parkinsonian rats.Potential therapeutic uses of mecamylamine and its stereoisomers.Neuroinflammation, neurodegeneration, and depression.Nicotine is neuroprotective when administered before but not after nigrostriatal damage in rats and monkeys.Nicotine reduces established levodopa-induced dyskinesias in a monkey model of Parkinson's disease
P2860
Q22252514-90CBD2E8-1087-4846-AB3E-6B20EA23469CQ26861923-BA804263-5935-48B9-891A-435CD41C2A19Q28386015-40866305-E747-4E0E-A8D0-1ACBE1FD33D9Q28391911-E66DC707-092C-411F-8081-248F6F379279Q28509139-778A509F-5771-436C-9042-5CB9419FB422Q28580629-7DF0B2EC-36BD-49A3-91F6-E00E586DA1A4Q28658136-2D957388-847C-4CEE-8696-18AA7DE70FCFQ30278808-B19C6574-AC6C-4656-9A85-80528C5E9EDBQ30372351-E244141A-16CE-49FC-9D44-1053871C67D4Q30416730-2AE94B80-F540-48F5-9E9B-3AA1FE4DDBADQ30451446-AB570018-61CF-43A6-94AB-CAAC34B1A008Q30489625-D59F11E1-A230-4EE3-9213-F29D0A6BEED4Q33624583-30A6D867-CA5E-4BB7-B716-44FC7566A112Q34112026-0D839EA5-3594-4BA4-80C3-A7DE0CBCE87BQ34212626-C830C7BE-23BC-46E8-AB6B-F9E9F20C85F6Q34219565-52868B27-2216-4DB1-A253-657F1CEC4DFEQ34229828-61DBBBD4-39B2-41D7-95F6-4E62EC3C5617Q34281003-EC1ECD17-D8B0-475F-8F4F-1E1E62CC82DDQ34309950-E03FBF5B-859A-4809-89AB-3323971D1F0CQ34326643-58E4DF4E-DBB4-426D-A0D2-384B56A06F05Q34485695-D4295686-12A4-45D8-942D-226FDC794F20Q34784487-2A805D65-2C3D-47DC-999E-1EFDF68ED510Q34793270-3FD3280D-F311-444F-91E2-B1D6F768F907Q35098275-D9EBBB5A-19DB-4E87-B76A-47F3D08E175FQ35173258-6B02641C-E559-477C-96B7-477622912755Q35179522-9637E797-D063-4F01-B64E-19D572D4C4A9Q35207319-6F60AC68-0523-4257-9F62-CBC5E8868239Q35264378-DBC699D4-A92C-43A4-91BB-C574A527B43BQ35541184-A60F446A-6CE0-4369-AD21-CE5B0110C2F4Q35549022-03D8C2DA-E827-4704-A37C-4D3747F05C08Q35632118-7F33DEDE-747D-49CA-8BCD-1626F81F0C7EQ35690145-0B49BBFE-FD1D-4B4D-A880-74BBA36FC0F0Q35776860-FFFECAD8-F8A5-4BC4-92C2-24D82DFB1863Q36039402-1D8DA53E-6DC8-494A-8C68-761EF1E43AAFQ36294431-6518E142-679A-4194-A35A-43758016131EQ36936930-D115165C-BD41-4BFD-912B-861F7DCF3BD8Q36949979-1C2B71D0-E76A-426F-8B6A-CEFC563803D4Q37116106-860907CC-30C9-4EF5-98D9-584B5F02CDBEQ37180827-48C6CE57-2C83-4E9D-941B-B7CDAA31DD0CQ37209730-DAD3D320-4F39-458F-B386-D9C9A1A374B9
P2860
Neuroprotection via nAChRs: the role of nAChRs in neurodegenerative disorders such as Alzheimer's and Parkinson's disease.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Neuroprotection via nAChRs: th ...... mer's and Parkinson's disease.
@en
type
label
Neuroprotection via nAChRs: th ...... mer's and Parkinson's disease.
@en
prefLabel
Neuroprotection via nAChRs: th ...... mer's and Parkinson's disease.
@en
P356
P1476
Neuroprotection via nAChRs: th ...... mer's and Parkinson's disease.
@en
P304
P356
10.2741/2695
P577
2008-01-01T00:00:00Z